
MD, PhD, medical oncology resident @uzleuven @KU_Leuven - passionate about biomarkers in clear-cell renal cell carcinoma 🇧🇪
Leuven
Joined April 2021
- Tweets32
- Following258
- Followers82
- Likes252
#PhDone! 👩🎓
Last week, I successfully defended my PhD on response prediction for systemic therapies in clear-cell RCC.
Incredibly grateful for the support of my supervisors professors Benoit Beuselinck, @AbhishekDGarg and @MaartenAlbersen!
Thanks as well to my jury members professors Els Wauters @ewauters, Jeroen Dekervel @JDekervel, Yann Vano and Henrik Heiland @MILOLab2, for their constructive feedback and insightful questions!
Finally, thanks to all my colleagues, family and friends who helped and supported me along the way.
After this amazing journey at @KU_Leuven @Onco_KULeuven, excited for my final 2 years of medical oncology training at @UZLeuven!
Lisa Kinget retweeted
📢Thrilled to share our lab's latest research on unique, #evolutionarily #conserved, TIM3+VISTA+ #macrophage subset that mediates #resistance to #anticancer #Immunotherapy & #chemotherapy! @ScienceAdvances 1/11🧵
📑Read here:
science.org/doi/10.1126/scia…
@OncoAlert @oncodaily @OncLive
Lisa Kinget retweeted
Read this excellent work by one of our young BSMO members @LisaKinget in @NatureMedicine
"A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma" @KidneyCancer @UZLeuven @mybsmo @AbhishekDGarg nature.com/articles/s41591-0…
Lisa Kinget retweeted
🚨Read @CD_AACR #ResearchWatch snippet on our recent work!
"A Multiomics-Informed HLA Signature Predicts Immunotherapy Response"
🗞️Read full paper here: nature.com/articles/s41591-0…
Cancer Discovery News #NotedThisWeek: A curated list of recent breaking news.
bit.ly/3VPPkqW
Lisa Kinget retweeted
⚡️ On @NatureMedicine - A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma
#KidneyCancer #Immunotherapy @OncoAlert @OncLive
nature.com/articles/s41591-0…
Lisa Kinget retweeted
🙏Thanks @CD_AACR for highlighting our recent research on #kidneycancer #immunotherapy & #immunology and #artificialintelligence driven #biomarkers!
@KU_Leuven @UZLeuven @KidneyCancer @LisaKinget
aacrjournals.org/cdnews/news… – at Herent, België
Lisa Kinget retweeted
GU Research Digest for the week of May 18 - 25: a selection of publications about GU cancers in high-impact journals. Search the PMIDs on pubmed.ncbi.nlm.nih.gov to read!
Lisa Kinget retweeted
Cell Stress and Immunity Lab - Heritable and spatial immunogenic traits predict efficacy of immunotherapy responses in kidney cancer patients
@AbhishekDGarg @NatureMedicine @LisaKinget @snaulrts @Zucmanrossi @MaartenAlbersen
oncodaily.com/73004.html
#Cancer #OncoDaily #Oncology
Lisa Kinget retweeted
Thrilled to share our lab's latest research on multiomics and spatial mapping of immunotherapy responses in kidney cancer patients - @AbhishekDGarg
@KU_Leuven @FWOVlaanderen @med_fac @UZLeuven @LKILeuven @komop_tgkanker
oncodaily.com/insight/70595.…
#Cancer #OncoDaily #Oncology
Lisa Kinget retweeted
This paper by @AbhishekDGarg and colleagues addresses some key questions in ccRCC, including some key features of responders to immunotherapy. Extremely useful read. Congratulations to all involved, wonderful work!
nature.com/articles/s41591-0…
Lisa Kinget retweeted
It is great to see the significant effect of HLA promiscuity in the ICB treatment of renal cancer. Congratulations to the authors, great study!
nature.com/articles/s41591-0…
#cancer #immunotherapy #hla #tumor #kidney #kidneycancer
@LisaKinget @Francesca_Fin_ @AbhishekDGarg
Lisa Kinget retweeted
The OncoAlert🚨NEWSLETTER OUT
Covering May 17-23 , 2024
REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe…
Discussing:
✅ICI’s 💉for POLE or POLD1 in met CRC
✅Advancements in mgt of Synchronous CRC Liver Mets
✅5yr outcome w/pembro💉 mono NSCLC🫁
✅SBRT☢️ in Lung Cancer🫁
✅RIGHT Choice in #BreastCancer 💊
✅Selection of Germline Genetic Testing Panels in Patients With Cancer: @ASCO Guidelines
✅A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma
✅Incidence of SLN mets in early #EndometrialCancer
✅Characterization of HER2-low 🧬breast cancer in young women with germline #BRCA 1/2 pathogenetic variants
@pashtoonkasi @margheambro1 @FilippoPietran4
@Mom_enji @Areeb_Lutfi @cihangirakyol
@Eda_Eylmr_Mcn @StephenVLiu @VamsiVelcheti
@HenningWillers @PercyLeeMD @Icro_Meattini @katsuki_arima @StoverLab @FrancescoSche20 @umangtalking @SGreenbergGC @vinay_onc
@neerajaiims @Lucarecco @LisaKinget
@drenriquegrande @IJGCfellows @JayrajAarthi
@IJGConline @matteolambe @BenWestphalen @DrYukselUrun @PGrivasMDPhD
#OncoAlertAF
@nataliagandur @acampsmalea @MartaPerachino @heinrich_kat @BiagioRicciutMD @DenizCanGuven1
@yekeduz_emre @HHorinouchi @FadiHaddad_MD
@Dr_Ivanoncologo @Abdallah81MD @FernandoOnco
@ElisaAgostinett @dr_yakupergun @to_be_elizabeth @anmwongNZ
Lisa Kinget retweeted
Spatial HLA signature may predicts response to immunotherapy in advanced renal cell carcinoma.
@NatureMedicine @OncoAlert #CancerResearch #oncology #kidney
nature.com/articles/s41591-0…
Lisa Kinget retweeted
⚡️ On @NatureMedicine - A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma
#KidneyCancer #Immunotherapy @OncoAlert @OncLive
nature.com/articles/s41591-0…
Lisa Kinget retweeted
Multiomics & spatial mapping of tumor samples from patients with advanced #RenalCellCarcinoma, as well as integration of transcriptomic and HLA genotyping data provides a machine learning-derived signature of response to #immune #CheckpointBlockade.
nature.com/articles/s41591-0…
Lisa Kinget retweeted
Incredible work unravelling key features of ICB responsiveness in RCC spearheaded by @LisaKinget @KU_Leuven, out now in @NatureMedicine!
📢Thrilled to share our lab's latest work where we found that #heritable & #spatial #immunogenic #traits predict efficacy of #immunotherapy responses in #kidneycancer #patients! @NatureMedicine
1/10🧵
@OncoAlert @oncodaily @Medi_Mix @OncLive
📑Read here: nature.com/articles/s41591-0…
Lisa Kinget retweeted
genomeweb.com/sequencing/kid… – at Herent, België
Incredibly proud to have my PhD project on #ICB in #RCC out in @NatureMedicine today!!
Thanks again to our patients, to my amazing mentors @AbhishekDGarg , @snaulrts and Benoit Beuselinck, and to all our collaborators! nature.com/articles/s41591-0…
Great 🧵 below👇👇👇
📢Thrilled to share our lab's latest work where we found that #heritable & #spatial #immunogenic #traits predict efficacy of #immunotherapy responses in #kidneycancer #patients! @NatureMedicine
1/10🧵
@OncoAlert @oncodaily @Medi_Mix @OncLive
📑Read here: nature.com/articles/s41591-0…
























